Fri, September 20, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, August 29, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 9, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, August 8, 2024
[ 12:00 AM ] - WOPRAI
Tue, July 9, 2024
[ 12:00 AM ] - WOPRAI
Fri, June 21, 2024
[ 12:00 AM ] - WOPRAI
Thu, June 20, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 31, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 30, 2024
[ 12:00 AM ] - WOPRAI
Tue, May 28, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 16, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 15, 2024
[ 12:00 AM ] - WOPRAI
Tue, May 14, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 10, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 2, 2024
[ 12:00 AM ] - WOPRAI
Tue, April 30, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, April 23, 2024
[ 12:00 AM ] - WOPRAI
Fri, April 19, 2024
[ 12:00 AM ] - WOPRAI
Thu, April 18, 2024
[ 12:00 AM ] - WOPRAI
Mon, April 1, 2024
[ 12:00 AM ] - WOPRAI
Wed, March 20, 2024
[ 12:00 AM ] - WOPRAI
Thu, February 29, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, February 15, 2024
Kristen Kluska Reiterated (SRPT) at Hold and Held Target at $152 on, Sep 20th, 2024
Kristen Kluska of Cantor Fitzgerald, Reiterated "Sarepta Therapeutics, Inc." (SRPT) at Hold and Held Target at $152 on, Sep 20th, 2024.
Kristen has made no other calls on SRPT in the last 4 months.
There are 11 other peers that have a rating on SRPT. Out of the 11 peers that are also analyzing SRPT, 1 agrees with Kristen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Hoang of "Citigroup" Maintained at Hold with Decreased Target to $160 on, Thursday, August 8th, 2024
These are the ratings of the 10 analyists that currently disagree with Kristen
- Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $181 on, Thursday, September 19th, 2024
- Biren Amin of "Piper Sandler" Maintained at Buy with Decreased Target to $200 on, Thursday, August 8th, 2024
- Gavin Clark-Gartner of "Evercore ISI Group" Upgraded from Hold to Buy and Decreased Target to $179 on, Thursday, August 8th, 2024
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $203 on, Thursday, August 8th, 2024
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $235 on, Thursday, June 27th, 2024
- Kostas Biliouris of "BMO Capital" Maintained at Buy with Increased Target to $200 on, Monday, June 24th, 2024
- Mani Foroohar of "Leerink Partners" Maintained at Buy with Increased Target to $230 on, Monday, June 24th, 2024
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $200 on, Monday, June 24th, 2024
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $213 on, Friday, June 21st, 2024
- Brian Skorney of "Baird" Maintained at Buy with Increased Target to $200 on, Friday, June 21st, 2024
Contributing Sources